Pre-IND submission to FDA targeted for first quarter 2024 Silo partners with Kymanox for SPC-15 ENGLEWOOD CLIFFS, NJ, Sept. 20, 2023 Silo Pharma, Inc. , a developmental stage.
Silo Pharma (SILO) Announces Positive Data on SPC-15 for PTSD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Silo Pharma (SILO) Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.